Health AI Central
Share:
Peer-Reviewed Publication
Cancer2026;132(13):e70510.July 1, 2026Letter

Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

Diana L Hanna1, Caroline G P Roberts2, Gayle S Jameson3, Denise J Roe4, Erkut Borazanci3, Alison R Zoller2, Joshua D Rabinowitz5, Stephen Gately6, Daniel D Von Hoff3,6,7,8,9, Drew W Rasco10
1Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
2Research Department, Virta Health, Denver, Colorado, USA.
3Oncology Division, HonorHealth Research Institute, Scottsdale, Arizona, USA.
4The University of Arizona Cancer Center, Tucson, Arizona, USA.
5Department of Chemistry, Lewis-Sigler Institute of Integrative Genomics, and Ludwig Institute for Cancer Research, Princeton University, Princeton, New Jersey, USA.
6TD2 Oncology, Scottsdale, Arizona, USA.
7Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA.
8Clinical Genomics and Therapeutics, Translational Genomics Research Institute, Phoenix, Arizona, USA.
9Department of Medical Oncology and Therapeutic Research, City of Hope, Duarte, California, USA.
10START-San Antonio, San Antonio, Texas, USA.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.